Kaempferol promotes flap survival by inhibiting ferroptosis and inflammation through network pharmacology and in vivo experiments
Wound Repair and Regeneration · 2025
DOI: 10.1111/wrr.13250 ↗Kurz gefasst
Fachartikel in der Zeitschrift Wound Repair and Regeneration, 2025. Verfasst von An Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, The Second School of Medicine…. Hauptthemen laut MEDLINE: Kaempferols, Ferroptosis, Rats, Sprague-Dawley, Reperfusion Injury. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Project of Wenzhou Science and Technology Bureau.
Abstract (Originalsprache)
Skin flap transplantation is a primary method for wound repair; however, postoperative skin flap necrosis remains a significant challenge. Kaempferol, a flavonol abundant in various foods, exhibits diverse pharmacological effects. This study investigated the potential targets of kaempferol for treating skin flap ischemia–reperfusion (I/R) injury through network pharmacology and molecular docking, followed by in vivo validation. Using SwissTargetPredict, PubChem, SymMap V2, and GeneCards databases, 174 potential target proteins of kaempferol were identified. KEGG and GO enrichment analyses, performed using R software, indicated that kaempferol promotes skin flap survival by modulating ferroptosis, TNF‐α, and NF‐κB signalling pathways. Molecular docking demonstrated stable binding between kaempferol and key proteins, including SIRT1 and NRF2. In vivo, a McFarlane skin flap model was established in Sprague–Dawley rats. Kaempferol treatment improved flap survival, enhanced perfusion areas and distal arteriole visualisation, and increased blood flow in the flap. Furthermore, kaempferol reduced neutrophil infiltration, alleviated oxidative stress, improved mitochondrial morphology and function, and inhibited the release of proinflammatory cytokines. Western blot and immunofluorescence analyses confirmed that kaempferol inhibited ferroptosis and inflammation while promoting flap survival. Mechanistically, kaempferol was found to activate SIRT1‐mediated HMGB1/TLR4/NF‐κB and NRF2/SLC7A11/GPX4 pathways, thereby promoting skin flap survival and mitigating I/R injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, The Second School of Medicine, Wenzhou Medical University, Wenzhou, China.
ORCID-Profile: Dingsheng Lin
Förderung
- National Natural Science Foundation of China
- Project of Wenzhou Science and Technology Bureau
Zitieren
APA
Wang, A., Yang, J., Deng, J., Wang, K., Chen, G., & Lin, D. (2025). Kaempferol promotes flap survival by inhibiting ferroptosis and inflammation through network pharmacology and in vivo experiments. Wound Repair and Regeneration. https://doi.org/10.1111/wrr.13250
Vancouver
Wang A, Yang J, Deng J, Wang K, Chen G, Lin D. Kaempferol promotes flap survival by inhibiting ferroptosis and inflammation through network pharmacology and in vivo experiments. Wound Repair and Regeneration. 2025. doi:10.1111/wrr.13250
BibTeX
@article{Wang2025,
author = {Wang, An and Yang, Jialong and Deng, Jiapeng and Wang, Kaitao and Chen, Guodong and Lin, Dingsheng},
title = {Kaempferol promotes flap survival by inhibiting ferroptosis and inflammation through network pharmacology and in vivo experiments},
journal = {Wound Repair and Regeneration},
year = {2025},
doi = {10.1111/wrr.13250}
}
EUVIMED